Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Owonikoko TK, Zhang G, Kim HS, Stinson RM, Bechara R, Zhang C, Chen Z, Saba NF, Pakkala S, Pillai R, Deng X, Sun SY, Rossi MR, Sica GL, Ramalingam SS, Khuri FR.
Owonikoko TK, et al. Among authors: saba nf.
J Transl Med. 2016 May 3;14(1):111. doi: 10.1186/s12967-016-0861-5.
J Transl Med. 2016.
PMID: 27142472
Free PMC article.
Clinical Trial.